Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9358227
APP PUB NO 20150126550A1
SERIAL NO

14556792

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives are disclosed. Specifically, the 6-amino quinazoline or 3-cyano quinoline derivatives presented by general formula (I), or tautomers, enantiomers, diastereomers, racemates or pharmaceutically acceptable salts thereof, or metabolites, metabolic precursors or prodrugs thereof, are protein kinase inhibitors, in which each substitutent group of general formula (I) is as defined in the specification.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHANGHAI HENGRUI PHARMACEUTICAL CO LTDNO 279 WENJING ROAD MINHANG DISTRICT SHANGHAI 200245
JIANGSU HENGRUI MEDICINE CO LTDNO 7 KUNLUNSHAN ROAD ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE LIANYUNGANG JIANGSU 222047 222047

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Li, Xin Shanghai, CN 946 7137
Wang, Bin Shanghai, CN 1095 9516

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 7, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00